We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GENERIC DECLARATORY JUDGMENT PROVISION LACKS TEETH
Brand firms are still using an effective tactic to delay competition despite a key provision for the generic drug industry in last year’s Medicare drug benefit, a patent attorney said.